Skip to main content
OpenTrials

Clinical trial condition

Uterine Diseases

Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.

3,055 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Uterine Diseases trial results

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

NCT05256225

Conditions
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 414 locations
View Trial Details
Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT05564377

Conditions
Adnexal Diseases, Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, +36 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 482 locations
View Trial Details
Recruiting

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

NCT07470853

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • START - Los Angeles Los Angeles, California, United States
  • SCRI - Florida Cancer Specialists Sarasota, Florida, United States
  • St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States
View Trial Details
Recruiting

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

NCT07198074

Conditions
Advanced Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
View all 251 locations
View Trial Details
Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

NCT07182149

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Normunity Investigational Site Denver, Colorado, United States
  • Normunity Investigational Site New Haven, Connecticut, United States
  • Normunity Investigational Site Minneapolis, Minnesota, United States
  • Normunity Investigational Site Maumee, Ohio, United States
View all 18 locations
View Trial Details
Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

NCT04895709

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +56 more
Locations
  • Community Cancer Institute Clovis, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of Iowa Iowa City, Iowa, United States
View all 47 locations
View Trial Details

Related conditions